Characteristics and modulation by thyrotropin-releasing hormone of an inwardly rectifying K+ current in patch-perforated GH3 anterior pituitary cells.
Hyperpolarization of patch-perforated GH3 rat anterior pituitary cells in high-K+ Ca(2+)-free medium reveals an inwardly rectifying K+ current. This current showed potential-dependent activation and inactivation kinetics, complete inactivation during strong hyperpolarization and rectification at depolarized potentials. The current was blocked by millimolar concentrations of external Cs+, Ba2+, Cd2+ and Co2+, but it was almost insensitive to tetraethylammonium, 4-aminopyridine and two dihydropyridines, nisoldipine and nitrendipine. Verapamil and methoxyverapamil produced a strong and reversible inhibition of the current. In the presence of 100 nM thyrotropin-releasing hormone (TRH), the current was reduced. This reduction was increased by holding the cell at more negative potentials and was accompanied by a shift in steady-state voltage dependence of inactivation towards more positive voltages. Furthermore, the current slowly returned to the initial levels upon washout. Treatment of the cell with the protein phosphatase inhibitor okadaic acid increased the magnitude of the inhibition caused by TRH. Moreover, the current did not return towards the control level during a 30-min washout period. It is concluded that protein phosphatases participate in modulation of the GH3 cell inwardly rectifying K+ channels by TRH. Furthermore, these data indicate that either a protein phosphatase or a factor necessary for its activation is lost under whole-cell mode, which could account for the permanent reduction of the current in response to TRH.
Barros
F
F
Departamento de Biología Funcional, Facultad de Medicina, Universidad de Oviedo, Spain.
Delgado
L M
LM
del Camino
D
D
de la Peña
P
P
D000818:Animals; D002460:Cell Line; D004594:Electrophysiology / Q000379:methods; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors; D010902:Pituitary Gland / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D011188:Potassium / Q000502:physiology*; D047428:Protein Kinase Inhibitors; D051381:Rats; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology*
D047428:Protein Kinase Inhibitors; D013973:Thyrotropin-Releasing Hormone; D010749:Phosphoprotein Phosphatases; D011188:Potassium